Neoadjuvant chemotherapy with irinotecan and mitomycin-C for locally advanced squamous cell carcinoma of the uterine cervix

Anticancer Research

Volumn 27, Issue 4 C, 2007, Pages 2721-2727

  Kokawa, Katsuji ^a   Nishimura, Ryuichiro ^b   Fujii, Tuneo ^c   Umesaki, Naohiko ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^c National Kure Hospital   (Japan)

Author keywords

Cervical carcinoma; Irinotecan; Mitomycin C; Neoadjuvant chemotherapy

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; IRINOTECAN; MITOMYCIN C;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DISEASE FREE SURVIVAL; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; HUMAN; KAPLAN MEIER METHOD; LEUKOPENIA; LIVER TOXICITY; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT RESPONSE; UTERINE CERVIX CARCINOMA; VOMITING;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MIDDLE AGED; MITOMYCIN; NEOADJUVANT THERAPY; NEOPLASM STAGING; UTERINE NEOPLASMS;

EID: 34547812226     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL 3rd, Walker JL and Gersell D: Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340: 1154-1161, 1999.
2. Thomas GM: Improved treatment for cervical cancer-concurrent chemotherapy and radiotherapy. N Engl J Med 340: 1198-1200, 1999.
3. Thigpen T, Shingleton H, Homesley H, Lagasse L and Blessing J: Cis-platinum in treatment of advanced or recurrent squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group. Cancer 48: 899-903, 1981.
4. Alberts DS, Kronmal R, Baker LH, Stock-Novack DL, Surwit EA, Boutselis JG and Hannigan EV: Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study. J Clin Oncol 11: 1791-1795, 1987.
5. Thigpen T, Vance RB and Khansur T: The platinum compounds and paclitaxel in the management of patients with carcinoma of the cervix. Semin Oncol 22: 67-72, 1995.
6. Alberts DS, Garcia D and Mason-Liddil N: Cisplatin in advanced cancer of the cervix: an update. Semin Oncol 18: 11-24, 1998.
7. Vermorken JB: The role of chemotherapy in squamous cell carcinoma of the uterine cervix: a review. Int J Gynecol Cancer 3: 129-142, 1993.
8. Sugiyama T, Nishida T, Hasuo Y, Fujiyoshi K and Yakushiji M: Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer. Gynecol Oncol 69: 130-136, 1998.
9. Benedetti-Panici P, Greggi S, Colombo A, Amoroso M, Smaniotto D, Giannarelli D, Amunni G, Raspagliesi F, Zola P, Mangioni C and Landoni F: Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol 20: 179-188, 2002.
10. Wall ME, Wani MC, Cook CE and Palmar KH: Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata. J Am Chem Soc 88: 3888-3890, 1996.
11. Kunimoto T, Nitta K, Tanaka T, Uehara N, Baba H, Takeuchi M, Yokokura T, Sawada S, Miyasaka T and Mutai M: Antitumor activity of 7-ethyl-10-[4-(1- piperidino)-10-piperidino]carbonyloxy-camptothecin, a novel water-soluble derivative of camptothecin, against murine tumors. Cancer Res 47: 5944-5947, 1987.
12. Matsuzaki T, Yokokura T, Mutai M and Tsuruo T: Inhibition of spontaneous and experimental metastasis by a new derivative of camptothecin, CPT-11, in mice. Cancer Chemother Pharmacol 21: 308-312, 1988.
13. Verschraegen CF, Levy T, Kudelka AP, Llerena E, Ende K, Freedman RS, Edwards CL, Hord M, Steger M, Kaplan AL, Kieback D, Fishman A and Kavanagh JJ: Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix. J Clin Oncol 15: 625-631, 1997.
14. Irvin WP, Price FV, Bailey H, Gelder M, Rosenbluth R, Durivage HJ and Potkul RK: A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervix. Cancer 82: 328-333, 1998.
15. Sugiyama T, Yakushiji M, Noda K, Ikeda M, Kudoh R, Yajima A, Tomoda Y, Terashima Y, Takeuchi S, Hiura M, Saji F, Takahashi T, Umesaki N, Sato S, Hatae M and Ohashi Y: Phase II study of irinotecan and cisplatin as first-line chemotherapy in advanced or recurrent cervical cancer. Oncology 58: 31-37, 2000.
16. Wasserman TH and Carter SK: The integration of chemotherapy into combined modality treatment of solid tumors. VIII. Cervical cancer. Cancer Treat Rev 4: 25-46, 1997.
17. Miyamoto T: A sequential combination of bleomycin and mitomycin C in the treatment of advanced squamous cancers. Recent Results Cancer Res 63: 179-190, 1978.
18. Villalona-Calero MA and Kolesar JM: Mitomycin as a modulator of irinotecan anticancer activity. Oncology 16: 21-25, 2002.
19. Umesaki N, Fujii T, Nishimura R, Tanaka T, Nishida M, Fushiki H, Takizawa K, Yamamoto K, Hasegawa K and Izumi R: Phase II study of irinotecan combined with mitomycin-C for advanced or recurrent squamous cell carcinoma of the uterine cervix: the JGOG study. Gynecol Oncol 95: 127-132, 2004.
20. Tanaka T, Kokawa K and Umesaki N: Preoperative chemotherapy with irinotecan and mitomycin for FIGO stage IIIb cervical squamous cell carcinoma: a pilot study. Eur J Gynaec Oncol 26: 605-607, 2005.
21. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET and Carbone PP: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 15: 649-655, 1982.
22. WHO Handbook for Reporting Results of Cancer Treatment. WHO Offset Publication No. 48. World Health Organization: Geneva 1979.
23. Takeuchi S, Noda K and Yakushiji M: Late phase II study of CPT-11, topoisomerase I inhibitor, in advanced cervical carcinoma. Proc Am Soc Clin Oncol 11: 224, 1992.
24. Sugiyama T, Nishida T, Kumagai S, Nishio S, Fujiyoshi K, Okura N, Yakushiji M, Hiura M and Umesaki N: Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer. Br J Cancer 81: 95-98, 1999.
25. Chitapanarux I, Tonusin A, Sukthomya V, Charuchinda C, Pukanhapan N and Lorvidhaya V: Phase II clinical study of irinotecan and cisplatin as first-line chemotherapy in metastatic or recurrent cervical cancer. Gynecol Oncol 89: 402-407, 2003.
26. Kano Y, Suzuki K, Akutsu M, Suda K, Inoue Y, Yoshida M, Sakamoto S and Miura Y: Effects of CPT-11 in combination with other anti-cancer agents in culture. Int J Cancer 50: 604-610, 1992.
27. Villalona-Calero MA and Kolesar JM: Mitomycin as a modulator of irinotecan anticancer activity. Oncology 16: 21-25, 2002.
28. Kokawa K, Mabuchi Y, Tanaka K, Yagi S, Yata C and Umesaki N: Apoptosis in cervical carcinoma after balloon occluded arterial infusion of anticancer drugs. Anticancer Res 26: 1413-1418, 2006.
29. Souhami L, Gil RA, Allan SE, Canary PC, Araujo CM, Pinto LH and Silveira TR: A randomized trial of chemotherapy followed by pelvic radiation therapy In stage IIIB carcinoma of the cervix. J Clin Oncol 9: 970-977, 1991.
30. Bloss JD, Blessing JA, Behrens BC, Mannel RS, Rader JS, Sood AK, Markman M and Benda J: Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 20: 1832-1837, 2002.
31. Narita M, Nagai E, Hagiwara H, Aburada M, Yokoi T and Kamataki T: Inhibition of beta-glucuronidase by natural glucuronides of kampo medicines using glucuronide of SN-38 (7-ethyl-10-hydroxycamptothecin) as a substrate. Xenobiotica 23: 5-10, 1993.
32. Abigerges D, Armand JP, Chabot GG, Da Costa L, Fadel E, Cote C, Herait P and Gandia D: Irinotecan (CPT-11) high-dose escalation using intensive high-dose loperamide to control diarrhea. J Natl Cancer Inst 86: 446-449, 1994.
33. Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, Heintz AP, Ngan HY, Sideri M and Pecorelli S: Carcinoma of the cervix uteri. J Epidemiol Biostst 6: 5-44, 2001.
34. Sardi JE, Giaroli A, Sananes C, Ferreira M, SoderiniA, Snaidas L, Vighi S, Gomez Rueda N and di Paola G: Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage lb squamous carcinoma of the cervix: the final results. Gynecol Oncol 67: 61-69, 1997.
35. Kumar L, Kaushal R, Nandy M, Biswal BM, Kumar S, Kriplani A, Singh R, Rath GK and Kochupillai V: Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: a randomized study. Gynecol Oncol 54: 307-315, 1994.
36. Symonds RP, Habeshaw T, Reed NS, Paul J, Pyper E, Yosef H, Davis J, Hunter R, Davidson SE, Stewart A, Cowie V and Sarkar T: The Scottish and Manchester randomized trial of neo-adjuvant chemotherapy for advanced cervical cancer. Eur J Cancer 36: 994-1001, 2000.